BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report)’s stock price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $1.09 and traded as low as $0.2194. BioRestorative Therapies shares last traded at $0.2455, with a volume of 13,598,275 shares traded.
BioRestorative Therapies Trading Down 40.5%
The stock’s fifty day simple moving average is $1.09 and its 200 day simple moving average is $1.34. The company has a market cap of $2.18 million, a price-to-earnings ratio of -0.17 and a beta of 0.39.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
Read More
- Five stocks we like better than BioRestorative Therapies
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
